Looking to publish in Translational Lung Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTranslational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.
Looking to publish in Translational Lung Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Translational Lung Cancer Research accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Systematic Reviews Without Meta-Analysis
Narrative Review (Also Called Literature Review)
Scoping Review
Clinical Practice Review
Mini-Review
Clinical Practice Guideline
Expert Consensus
Case Series
Case Report
Brief Report
Letter To The Editor
Recent Publications
Pathological and molecular characterization of a four-component combined small cell lung carcinoma: a case report
Yasuyuki Ikezawa, Yoshiki Shinomiya, Kanako C. Hatanaka, Keishi Makita, Hiroki Nishimura, Toichiro Takagi, Yukiko Tabata, Mikio Watanabe, Satoshi Konno, Yutaka Hatanaka, Yasutaka Kawai
CEACAM5 as a biomarker of semi-solid, lepidic lung adenocarcinoma
Justin M. Bader, William de Santis, Emma Kane, Anjali Jaiswal, Christina Cho, Michal Kidacki, Lieping Chen, Sanja Dacic, Gavitt A. Woodard
Neoadjuvant chemo-immunotherapy in a kidney transplant recipient with locally advanced non-small cell lung cancer: a case report of a therapeutic dilemma
Joffroy Rogier, Lucie Charon, Anne Durlach, Maxime Dewolf, Laëtitia Mokri, Antoine Braconier, Gaëtan Deslee, Julien Ancel
Targeting heterogeneity in atypical epidermal growth factor receptor-mutated non-small cell lung cancer: insights from CHRYSALIS-2
Yosuke Dotsu, Hiroshi Mukae
Pulmonary ground-glass opacity associated with cystic airspace: clinicopathological features and aggressiveness
Ziwen Yu, Jianfu Li, Hongsheng Deng, Caichen Li, Zhuxing Chen, Shan Xiong, Feng Li, Ran Zhong, Haixuan Wang, Chunyan Li, Danman Zhong, Yimin Zhong, Liping Liu, Wenhua Liang, Jianxing He
Frequently asked questions
How long does it take to publish?
In-house review takes 1-3 weeks. External peer review takes 1-3 months. Publication ahead of print occurs within 1 month after acceptance with APC payment received. Formal publication occurs within 1-3 months after acceptance with APC payment received. Original Articles are listed as priority.
Reformat to Translational Lung Cancer Research using Livewrite PremiumIs a cover letter required?
Authors must disclose any use of AI tools in the cover letter, Materials and Methods, and Acknowledgment.
Reformat to Translational Lung Cancer Research using Livewrite PremiumWhat are the publication costs?
Article processing charges apply.
Reformat to Translational Lung Cancer Research using Livewrite Premium